Inventor · disambiguated record
Philip Christopher Buxton
Also filed as: BUXTON PHILIP C · BUXTON PHILIP CHRISTOPHER
22 granted patents·14 pending applications·320 citations·filing 1986–2025
96Inventor score
Files withEAGLE PHARMACEUTICALS INC18SCIDOSE LLC4SCIDOSE PHARMA LLC3AuroMedics Pharma LLC2GLAXOSMITHKLINE LAB2
Top patents by PatentIndex Score
36 records- 0198US12138248B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2024·Granted Nov 12, 2024·3 cites·22 claims
- 0298US11872214B2Formulations of BendamustineEAGLE PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·3 cites·9 claims
- 0398US11844783B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2022·Granted Dec 19, 2023·5 cites·14 claims
- 0498US11103483B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2019·Granted Aug 31, 2021·9 cites·16 claims
- 0597US8609707B2Formulations of bendamustinePALEPU NAGESH R·Filed 2011·Granted Dec 17, 2013·42 cites·22 claims
- 0696US10010533B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·14 cites·26 claims
- 0796US9572796B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·16 cites·26 claims
- 0896US9572797B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·16 cites·27 claims
- 0996US9265831B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2013·Granted Feb 23, 2016·23 cites·6 claims
- 1094US9655898B2Pharmaceutical compositions containing pemetrexed having extended storage stabilityPALEPU NAGESH R·Filed 2011·Granted May 23, 2017·29 cites·18 claims
- 1193US10376559B2Formulations of vancomycinSCIDOSE LLC·Filed 2017·Granted Aug 13, 2019·5 cites·16 claims
- 1293US2025177356A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1392US12343333B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·0 cites·14 claims
- 1492US4721723AAnti-depressant crystalline paroxetine hydrochloride hemihydrateBEECHAM GROUP PLC·Filed 1986·Granted Jan 26, 1988·133 cites·6 claims
- 1591US11497789B2Formulations of vancomycinSCIDOSE PHARMA LLC·Filed 2020·Granted Nov 15, 2022·2 cites·18 claims
- 1691US10864250B2Formulations of vancomycinSCIDOSE LLC·Filed 2019·Granted Dec 15, 2020·3 cites·14 claims
- 1790US2024075013A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1888US2025295637A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1986US8809308B2Enema composition for treatment of ulcerative colitis having long term stabilitySCIDOSE LLC·Filed 2013·Granted Aug 19, 2014·3 cites·29 claims
- 2085US2025009838A1Formulations of vancomycinSCIDOSE PHARMA LLC·Filed 2024·Application pending·0 cites
- 2182US12350257B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2025·Granted Jul 8, 2025·0 cites·23 claims
- 2282US9662342B2Formulations of cyclophosphamide liquid concentrateAuroMedics Pharma LLC·Filed 2015·Granted May 30, 2017·5 cites·19 claims
- 2381US12220441B2Formulations of vancomycinSCIDOSE PHARMA LLC·Filed 2022·Granted Feb 11, 2025·0 cites·18 claims
- 2481US2021393594A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2572US2018296536A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2672US2018296535A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2769US9238037B2Enema composition for treatment of ulcerative colitis having long term stabilitySCIDOSE LLC·Filed 2014·Granted Jan 19, 2016·0 cites·21 claims
- 2860US2009221622A1Topotecan ready to use solutionsEAGLE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2955USRE39384ESubstituted thiazolidinedione derivativesSMITHKLINE BEECHAM PLC·Filed 2003·Granted Nov 7, 2006·1 cites·13 claims
- 3054US2005148582A1Novel compositionGLAXOSMITHKLINE LAB·Filed 2005·Application pending·0 cites
- 3150US2003032640A1Novel compositionFiled 2002·Application pending·0 cites
- 3250US2013210879A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3346US6428808B1Pharmaceutical composition prepared by addition of a flavor vehicle to a medicamentSMITHKLINE BEECHAM PLC·Filed 1996·Granted Aug 6, 2002·8 cites·2 claims
- 3443US2006057218A1Novel compositionGLAXOSMITHKLINE LAB·Filed 2005·Application pending·0 cites
- 3543US2017232015A1Formulations of cyclophosphamide liquid concentrateAuroMedics Pharma LLC·Filed 2017·Application pending·0 cites
- 3636US2005075335A1Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulationFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Christopher Buxton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →